Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Allergy is the immune reaction to foreign body called allergen; it may arise due to food consumed or inhaled into lungs or in contact with skin through injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in U.S. Over the period of 50 years of global industrialization, there is a substantial rise in prevalence of allergic diseases. According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% - 40% across all age groups of population. Allergic disease affects more than one billion people worldwide and is anticipated to reach 4 billion in 2050. This increases both direct and indirect burden in terms of rise in healthcare cost, loss of productivity and adverse effect on quality of life. Thus increase in prevalence of allergic diseases and novel diagnostic and treatment products entering the market are the key factors governing the growth of allergy diagnostics and treatment market.

The report titled “Allergy Diagnostics and Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall allergy diagnostics and treatment market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of diagnostic products, allergens, tests, treatments and different geographies. 

The diagnostic product types studied for analyzing the overall global allergy diagnostics and treatment market are majorly segmented into instruments, consumables, services and other products. By allergen type, the allergy diagnostics and treatment market is segmented into food, inhaled, drug and other allergens. On the basis of test types, it is further segmented as in vivo and in vitro tests. According to treatment type, the market is segmented into antihistamines, autoinjectables epinephrine, corticosteroids, decongestants, immunomodulators, immunotherapy, leukotriene inhibitors, mast cell stabilizers and nasal anticholinergics.

Geographically, the global allergy diagnostics and treatment market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa
  •  

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year. Further cross-sectional presented in terms of diagnostic products, allergens, test, treatment and constituent country level markets is also included in this section.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global allergy diagnostics and treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global allergy diagnostics and treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global allergy diagnostics and treatment market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the allergy diagnostics and treatment market. The key players profiled in this report are Alcon Laboratories, Inc., bioMerieux, Danaher Corporation, Hitachi Chemical Diagnostics, HOB Biotech Group, Hycor Biomedical, Lincoln Diagnostics, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Thermo Fisher Scientific and others.

Based on the type of treatment, the global allergy treatment market is segmented as follows:

• Antihistamines
• Autoinjectable Epinephrine
• Corticosteroids
• Decongestants
• Immunomodulators
• Immunotherapy
• Leukotriene Inhibitors
• Mast Cell Stabilizers
• Nasal Anticholinergics

In 2016, antihistamine is the most commonly used treatment for allergic diseases, thus dominates the global allergy treatment market.  Next followed up market is of corticosteroids, which are highly effective drugs for allergies. Immunotherapy is expected to be the fastest growing segment in allergy treatment market. Immunotherapy is showing fast adoption as it is cost effective, decreases sensitivity to allergens and provides long lasting relief from allergy symptoms.

Based on the type of allergen, the global allergy diagnostics and treatment market is segmented as follows:

• Food Allergens
• Inhaled Allergens
• Drug Allergens
• Other

Rising incidence of inhaled allergies and asthma due to growing pollution, urbanization contribute to the growth of allergy diagnostics and treatment market. Thus inhaled allergens occupy the largest revenue share for the year 2016. Allergic rhinitis affects almost 10% - 30% of the adult population and 40% of children. Global warming, alteration in pollination season are some of the major reasons for growing incidence of asthma and allergic rhinitis. Food allergies are commonly observed in children than in adults. Drug allergen is anticipated to be the fastest growing segment during the forecast period 2017-2025.

For the purpose of this study, the global allergy diagnostic and treatment market is geographically categorized into:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe)
• Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • UAE
  • Saudi  Arabia
  • South Africa
  • Rest of Middle East and Africa

At present, North America occupies the largest share of global allergy diagnostic and treatment market followed by Europe. Rising incidence of allergic diseases particularly related to respiratory function, increasing awareness of allergy diagnostics, well supported healthcare structure, favorable reimbursement policies and enhanced diagnostic technology are some of the major driving factors for allergy diagnostics and treatment market. Around 150 million Europeans suffer from chronic allergic diseases and it is predicted to cover almost half the population of Europe by 2025. Rise in geriatric population are key factors which would further fuel the allergy diagnostics and treatment market. 

Asia Pacific is anticipated to be the fastest growing allergy diagnostics and treatment market in the forecast period. Rising prevalence of allergic diseases and asthma, particularly in developing countries poses major threat to health and economies. Thus high unmet needs, improving healthcare infrastructure, rising pollution, and increasing disposable income are some of the factors governing the demand of allergy diagnostics and treatment market in Asia Pacific region.